NewslettersCell Therapy NewsMAGE-A4 pMHC-Targeted CAR-T Cells Exploiting TCR Machinery Exhibit Significantly Improved In Vivo Function While Retaining Antigen SpecificityBy Jamie Kang - November 25, 20240788Researchers determined whether MAGE-A4 pMHC-targeted CAR-T cells using the T cell receptor machinery exhibited superior functionality without compromising antigen specificity.[Journal of Immunotherapy of Cancer]Full Article